FINWIRES · TerminalLIVE
FINWIRES

澳大利亚股市小幅收跌;Zip公布第三财季EBITDA增长,并上调2026财年业绩展望。

-- 周五收盘时,澳大利亚股市小幅走低,投资者正等待周末美伊外交磋商的结果。 S&P/ASX 200 指数下跌 0.1%,或 8.1 点,收于 8,946.90 点。 美国总统唐纳德·特朗普宣布黎巴嫩和以色列之间停火 10 天,并表示美伊会谈可能在周末举行。布伦特原油期货价格下跌超过 1%,至每桶 98.14 美元。现货黄金价格上涨近 1%,至每盎司 4,830.82 美元。 在国内方面,据西太平洋银行的一份报告显示,澳大利亚的信用卡活动在 3 月份季度增长了 1.2%,但季度增长势头疲软,低于 2025 年 6 月、9 月和 12 月季度 2% 的平均水平。截至4月11日的三周内,西太平洋银行-DataX信用卡追踪指数下跌2.2点。 公司新闻方面,Zip(ASX:ZIP)周五公布,其第三财季税前折旧摊销前现金收益(EBTDA)为每股6510万澳元,高于去年同期的4600万澳元。该公司表示,已将2026财年集团现金EBTDA预期上调至不低于2.6亿澳元。 美国铝业公司(ASX:AAI)周五公布,其第一财季调整后每股收益为1.40澳元,低于去年同期的2.15澳元。该公司预计,2026年氧化铝业务总产量和出货量将与此前预测保持一致,分别为970万至990万吨和1180万至1200万吨。 最后,Paladin Energy(ASX:PDN)表示,目前预计其位于纳米比亚的Langer Heinrich矿2026财年的八氧化三铀产量将在450万至480万磅之间,高于此前预期的400万至440万磅。该公司股价在交易日内触及近两年来的最高点。

Related Articles

Asia

National Australia Bank Shares Down After Resolution of Union Court Proceedings

National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."

$ASX:NAB
Asia

Clinuvel Pharmaceuticals Says FDA Removes Post-Authorization Requirement for Implant

Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.

$ASX:CUV
Asia

XRF Scientific Completes Acquisition of Combustion Gas Analysis Business

XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.

$ASX:XRF